ARCHIVES

No Protective Effect From Long-Term Vitamin E or C

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | November 28, 2008

Download PDF Visit The Full Archive

Related Articles

Foundation sees Grants Applications On Chronic Conditions

February 16, 1996

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

November 20, 1998

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013

Organ Systems Support Contract To Cost More than OSCC Grant

September 30, 1988

Texas Voters Approve $3 Billion In Bonds For Cancer Research.

November 9, 2007